Classification of human chromosome 21 gene-expression variations in down syndrome: impact on disease phenotypes

Aït Yahya-Graison, E., Aubert, J., Dauphinot, L., Rivals, I., Prieur, M., Golfier, G., Rossier, J., Personnaz, L. +5 more·2007·The American Journal of Human Genetics
DOI 10.1086/520000

Cited by (339)

Items 101–200 of 339

  1. Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions
    Aidan J. Murphy, Steve Donald Wilton, May Thandar Aung-Htut, Craig Stewart McIntosh · 2024 · Frontiers in Molecular Neuroscience
  2. The emerging and diverse roles of the SLy/SASH1‐protein family in health and disease—Overview of three multifunctional proteins
    Jennifer Jaufmann, Fabian Christoph Franke, Andreas Sperlich, Carolin Blumendeller, Isabel Kloos, Barbara Schneider, Daisuke Sasaki, Klaus‐Peter Janssen, Sandra Beer‐Hammer · 2021 · The FASEB Journal
  3. Brain Phenotype of Transgenic Mice Overexpressing Cystathionine β-Synthase
    Vinciane Régnier, Jean‐Marie Billard, Sapna Gupta, Brigitte Potier, Stéphanie Woerner, Evelyne Paly, Aurélie Ledru, Sabrina David, Sabrina Luilier, Jean‐Charles Bizot et al. · 2012 · PLoS ONE
  4. Genome-Wide Expression Analysis in Down Syndrome: Insight into Immunodeficiency
    Chong V. Li, Lei Jin, Yun Bai, Qimin Chen, Lijun Fu, Minjun Yang, Huasheng Xiao, Guoping Zhao, Shengyue Wang · 2012 · PLoS ONE
  5. Genomic determinants in the phenotypic variability of Down syndrome
    Audrey Letourneau, Stylianos E. Antonarakis · 2012 · Progress in brain research
  6. Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2–ERG fusion status
    Kuwong B. Mwamukonda, Y Chen, Lakshmi Ravindranath, Bungo Furusato, Y Hu, Joseph R. Sterbis, D Osborn, Inger L. Rosner, Isabell A. Sesterhenn, David G. McLeod et al. · 2009 · Prostate Cancer and Prostatic Diseases
  7. The HSA21 gene EURL/C21ORF91 controls neurogenesis within the cerebral cortex and is implicated in the pathogenesis of Down Syndrome
    Shanshan Li, Zhengdong Qu, Matilda Haas, Linh Ngo, You Jeong Heo, Hyo Jung Kang, Joanne Maria Britto, Hayley Daniella Cullen, Hannah Kate Vanyai, Seong‐Seng Tan et al. · 2016 · Scientific Reports
  8. An emerging perspective on ‘histone code’ mediated regulation of neural plasticity and disease
    Lorna A. Farrelly, Ian S. Maze · 2019 · Current Opinion in Neurobiology
  9. Expression of trisomic proteins in Down syndrome model systems
    Claire Spellman, Md. Mahiuddin Ahmed, Daphne Dubach, Katheleen Gardiner · 2012 · Gene
  10. Altered immune parameters correlate with infection-related hospitalizations in children with Down syndrome
    Elizabeth Martínez, Diana Castañeda, Sonia Jaramillo, Alejandro Iregui, Tatiana Quiñonez, Jairo Antonio Rodríguez, Eddy Herrera Daza, Ana Milena Gómez, Martín Rondón, Juan Carlos Prieto et al. · 2016 · Human Immunology
  11. Differentially expressed gene (DEG) based protein-protein interaction (PPI) network identifies a spectrum of gene interactome, transcriptome and correlated miRNA in nondisjunction Down syndrome
    Sriroopreddy Ramireddy, Rakshanda Sajeed, P. Raghuraman, Chinnappan Sudandiradoss · 2018 · International Journal of Biological Macromolecules
  12. Echocardiography in children with Down syndrome
    Mohammed A Al-Biltagi · 2013 · World Journal of Clinical Pediatrics
  13. Atherosclerotic Surrogate Markers in Adults With Down Syndrome: A Case‐Control Study
    Pedro Parra, Ramon Junior Santos da Costa, Diego Real de Asúa, Fernando Moldenhauer, Carmen Suárez · 2016 · Journal of Clinical Hypertension
  14. Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome
    Sarah E. Lee, Monica Duran-Martinez, Sabina Khantsis, D. Bianchi, F. Guedj · 2019 · Trends in Molecular Medicine
  15. Hypomethylation and Genetic Instability in Monosomy Blastocysts May Contribute to Decreased Implantation Potential
    Blair R. McCallie, Jason C. Parks, Alyssa L. Patton, Darren Karl Griffin, William B. Schoolcraft, Mandy G. Katz‐Jaffe · 2016 · PLoS ONE
  16. Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants
    Carlos Alberto Moreira‐Filho, Sílvia Yumi Bando, Fernanda Bernardi Bertonha, Filipi N. Silva, Luciano da Fontoura Costa, Leandro Ferreira, Gláucio Furlanetto, Paulo Chaccur, Maria Cláudia Nogueira Zerbini, Magda Maria Sales Carneiro-Sampaio · 2016 · Oncotarget
  17. BDNF and DYRK1A Are Variable and Inversely Correlated in Lymphoblastoid Cell Lines from Down Syndrome Patients
    Asma Tlili, Alexander Hoischen, Clémentine Ripoll, Eva Benabou, Anne Badel, Anne Ronan, Renaud L. Touraine, Yann Grattau, Samantha Stora, Bregje W.M. van Bon et al. · 2012 · Molecular Neurobiology
  18. Trisomy 21 Alters DNA Methylation in Parent-of-Origin-Dependent and -Independent Manners
    Antônio Francisco Alves da Silva, Filipe Brum Machado, Érika Cristina Pavarino, Joice Matos Biselli, Bruna Lancia Zampieri, Ronaldo da Silva Francisco, Pedro Thyago Mozer Rodrigues, Douglas Terra Machado, Cíntia Barros Santos-Rebouças, Maria Gomes Fernandes et al. · 2016 · PLoS ONE
  19. Interindividual Variability in the Cardiac Expression of Anthracycline Reductases in Donors With and Without Down Syndrome
    Adolfo Quiñones‐Lombraña, Daniel C. J. Ferguson, Rachael Hageman Blair, James L. Kalabus, Almedina Redzematovic, Javier G. Blanco · 2014 · Pharmaceutical Research
  20. Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome
    Sasha L. Fulton, Wendy Wenderski, Ashley E. Lepack, Andrew L. Eagle, Tomas Fanutza, Ryan M. Bastle, Aarthi Ramakrishnan, Emma Catherine Hays, Arianna Neal, Jaroslav M. Bendl et al. · 2022 · Nature Communications
  21. Understanding the genetic mechanisms and cognitive impairments in Down syndrome: towards a holistic approach
    Yara Abukhaled, Kenana Hatab, Mohammad Awadhalla, Hamdan Hamdan · 2023 · Journal of Neurology
  22. 19p13.2 microduplication causes a Sotos syndrome‐like phenotype and alters gene expression
    Anna Lehman, Christèle du Souich, D Chai, Patrice Eydoux, JL Huang, AK Fok, Luana Avila, James T. Swingland, AD Delaney, Barbara C. McGillivray et al. · 2010 · Clinical Genetics
  23. Non‐trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome
    Cherie N. Billingsley, Jared Allen, Douglas D. Baumann, Samantha Deitz McElyea, Joshua D. Blazek, Abby Newbauer, Andrew Darrah, Bradley C. Long, Brandon Michael Young, Mark Clement et al. · 2013 · American Journal of Medical Genetics Part A
  24. Identification ofInverse Regulator-a(Inr-a) as Synonymous with Pre-mRNA Cleavage Complex II Protein (Pcf11) in Drosophila
    Weiwu Xie, James A. Birchler · 2012 · G3 Genes Genomes Genetics
  25. Differentially expressed miRNAs in trisomy 21 placentas
    Iveta Svobodová, Marie Korabečná, Pavel Calda, Miroslav Brestak, Eva Pazourková, Šárka Pospíšilová, M Krkavcová, Michaela Novotná, Aleš Hořínek · 2016 · Prenatal Diagnosis
  26. Epigenomic engineering for Down syndrome
    Alexios‐Fotios A. Mentis · 2016 · Neuroscience & Biobehavioral Reviews
  27. Expression Signature as a Biomarker for Prenatal Diagnosis of Trisomy 21
    Marija Volk, Aleš Maver, Luca Lovrečić, Peter Juvan, Borut Peterlin · 2013 · PLoS ONE
  28. Developmental molecular and functional cerebellar alterations induced by PCP4/PEP19 overexpression: Implications for Down syndrome
    François Mouton‐Liger, Ignasi Sahún, Thibault Collin, Patricia Lopes Pereira, Débora Masini, Sophie Thomas, Evelyne Paly, Sabrina Luilier, Sandra Même, Quentin Jouhault et al. · 2013 · Neurobiology of Disease
  29. Concise Review: New Paradigms for Down Syndrome Research Using Induced Pluripotent Stem Cells: Tackling Complex Human Genetic Disease
    James Briggs, Elizabeth A. Mason, Dmitry A. Ovchinnikov, Christine Anne Wells, Ernst Jurgen Wolvetang · 2013 · Stem Cells Translational Medicine
  30. Interaction Study of the Male Specific Lethal (MSL) Complex and Trans-Acting Dosage Effects in Metafemales of Drosophila melanogaster
    Xiaoping Sun, James A. Birchler · 2009 · Cytogenetic and Genome Research
  31. Genome-wide miRNA profiling in plasma of pregnant women with down syndrome fetuses
    Iveta Zednikova, Blanka Chylíková, Ond⊘řej Šeda, Marie Korabečná, Eva Pazourková, Miroslav Brestak, M Krkavcová, Pavel Calda, Aleš Hořínek · 2020 · Molecular Biology Reports
  32. Cell models for Down syndrome-Alzheimer’s disease research
    Yixing Wu, Nicole R. West, Anita Bhattacharyya, Frances K. Wiseman · 2022 · Neuronal Signaling
  33. Sprouty gene dosage influences temporal-spatial dynamics of primary enamel knot formation
    Kateřina Lochovská, Renata Peterková, Zuzana Pavlíková, Mária Hovořáková · 2015 · BMC Developmental Biology
  34. Recuperação pôndero-estatural em crianças com síndrome de Down e cardiopatia congênita
    Nathalie Jeanne Bravo‐Valenzuela, Maria Lúcia Bastos Passarelli, Verônica Coates, Luiz Fernando Costa Nascimento · 2011 · Brazilian Journal of Cardiovascular Surgery
  35. Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome
    Bani Bandana Ganguly, Nitin N. Kadam · 2022 · Mitochondrion
  36. Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21
    Aarti Ruparelia, Frances K. Wiseman, Olivia Sheppard, Victor L. J. Tybulewicz, Elizabeth Fisher · 2010 · Journal of Biomedical Research
  37. A novel mouse model for Down syndrome that harbor a single copy of human artificial chromosome (HAC) carrying a limited number of genes from human chromosome 21
    Ken‐ichi Miyamoto, Nobutaka Suzuki, Kosuke Sakai, Shuichi Asakawa, Tsuneko Okazaki, Jun Kudoh, Masashi Ikeno, Nobuyoshi Shimizu · 2013 · Transgenic Research
  38. C21orf57 is a human homologue of bacterial YbeY proteins
    A. Ghosal, Caroline Kohrer, V. M. Babu, Kinrin Yamanaka, B. Davies, A. Jacob, Daniel J. Ferullo, Charley Gruber, M. Vercruysse, G. Walker · 2017 · Biochemical and Biophysical Research Communications - BBRC
  39. Down syndrome: A curative prospect?
    Jean Adolphe Rondal · 2020 · AIMS neuroscience
  40. Genetics and genomics of Down syndrome
    Pierluigi Strippoli, Maria Chiara Pelleri, Allison Piovesan, Maria Caracausi, Francesca Antonaros, Lorenza Vitale · 2019 · International review of research in developmental disabilities
  41. Modulation of Global Gene Expression by Aneuploidy and CNV of Dosage Sensitive Regulatory Genes
    Shuai Zhang, Ruixue Wang, Cheng Huang, Ludan Zhang, Lin Sun · 2021 · Genes
  42. C21orf91 Regulates Oligodendroglial Precursor Cell Fate—A Switch in the Glial Lineage?
    Laura Reiche, Peter Göttle, Lydie Lane, Paula D Duek, Mina Park, Kasum Azim, Jana Schütte, Anastasia Manousi, Jessica Schira‐Heinen, Patrick Küry · 2021 · Frontiers in Cellular Neuroscience
  43. Epigenome-wide base-resolution profiling of DNA methylation in chorionic villi of fetuses with Down syndrome by methyl-capture sequencing
    Ji Hyae Lim, Yu-Jung Kang, Bom Yi Lee, You Jung Han, Jin Hoon Chung, Moon Young Kim, Min Hyoung Kim, Jin‐Woo Kim, Youl-Hee Cho, Hyun Mee Ryu · 2019 · Clinical Epigenetics
  44. Gene expression profiling of amniotic fluid mesenchymal stem cells of monozygotic twins discordant for trisomy 21
    Shu-Han You, Yun‐Shien Lee, Yu-Jen Chang, Chiao‐Yun Lin, Tzu‐Hao Wang, Yao‐Lung Chang · 2020 · Gene
  45. Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
    Victor Faúndez, Ilario De Toma, Barbara Bardoni, Renata Bartesaghi, Dean Nižetić, Rafael de la Torre, Roi Cohen Kadosh, Yann Hérault, Mara Dierssen, Marie‐Claude Potier et al. · 2018 · European Neuropsychopharmacology
  46. Surveying the Down syndrome mouse model resource identifies critical regions responsible for chronic otitis media
    Mahmood Fazal Bhutta, Michael T Cheeseman, Yann Hérault, Yuejin E. Yu, Steve D. M. Brown · 2013 · Mammalian Genome
  47. Genomic Responses to Abnormal Gene Dosage: The X Chromosome Improved on a Common Strategy
    Xinxian Deng, Christine M. Distèche · 2010 · PLoS Biology
  48. Aneuploidy: the impact of chromosome imbalance on nuclear organization and overall genome expression
    Bérénice Herve, Aurélie Coussement, T. Gilbert, Florent Dumont, S. Jacques, Laurence Cuisset, Mathieu Chicard, S. Hizem, Pierre Bourdoncle, Franck Letourneur et al. · 2016 · Clinical Genetics
  49. Comparative analysis of the DYRK1A-SRSF6-TNNT2 pathway in myocardial tissue from individuals with and without Down syndrome
    Adolfo Quiñones‐Lombraña, Javier G. Blanco · 2019 · Experimental and Molecular Pathology
  50. Neuro-Ophthalmological Manifestations in Children with Down Syndrome: Current Perspectives
    Lavinia Postolache, Anne Monier, Sophie Lhoir · 2021 · Eye and Brain
  51. DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients
    Manon Moreau, María Carmona‐Iragui, Miren Altuna, Lorraine Dalzon, Isabel Barroeta, Marie Vilaire-Meunier, Sophie Durand, Juan Fortea, Anne‐Sophie Rebillat, Nathalie Janel · 2022 · Biomedicines
  52. Expression of the DYRK1A gene correlates with its 3D positioning in the interphase nucleus of Down syndrome cells
    Nerea Paz, Izaskun Felipe-Blanco, Félix Royo, Amaia Zabala‐Letona, Isabel Guerra‐Merino, África García‐Orad, Jose Luis Zugaza, Luis Antonio Parada · 2015 · Chromosome Research
  53. Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model
    Hawley, Laura E., Stringer, Megan, Deal, Abigail J., Folz, Andrew, Goodlett, Charles R., Roper, Randall J. · 2024 · Neurobiology of Disease
  54. Down syndrome: from the age of characterization to the era of curative approach
    Bani Bandana Ganguly, Nitin N. Kadam · 2016 · The Nucleus
  55. Characterization of PTZ-Induced Seizure Susceptibility in a Down Syndrome Mouse Model That Overexpresses CSTB
    Véronique Brault, Benoı̂t Martin, Nathalie Costet, Jean‐Charles Bizot, Yann Hérault · 2011 · PLoS ONE
  56. Autosomal Reciprocal Translocations
    R. J McKinlay Gardner, David J. Amor · 2018 · Oxford University Press eBooks
  57. A 15q24 microdeletion in transient myeloproliferative disease ( TMD ) and acute megakaryoblastic leukaemia ( AMKL ) implicates PML and SUMO 3 in the leukaemogenesis of TMD / AMKL
    Susanne Hämmerling, Wolfgang Behnisch, Tobias Doerks, Jan O. Korbel, Peer Bork B, Ute Moog, Sabine Hentze, Ute Grasshoff, Michael von Bonin, Olaf Rieß et al. · 2012 · British Journal of Haematology
  58. Down Syndrome, Other Full Aneuploidies, and Polyploidy
    R. J. M. Gardner, Grant R. Sutherland, Lisa G. Shaffer · 2011 · Oxford University Press eBooks
  59. Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model
    Guido N. Vacano, David S. Gibson, Abdullah Arif Turjoman, Jeremy W. Gawryluk, Jonathan D. Geiger, Mark William Duncan, David Patterson · 2017 · Neurobiology of Aging
  60. Molecular cartography of the human down syndrome and trisomic mouse brain
    Min Yi Feng, Wuxinhao Cao, Nareh Tahmasian, Bharti Kukreja, Gen Lin Li, Bianca Rusu, Ji‐Young Youn, Brian Thomas Kalish · 2025 · Nature Communications
  61. Increased plasma DYRK1A with aging may protect against neurodegenerative diseases
    Jean Maurice Delabar, Julien Lagarde, Marta Fructuoso, Ammara Mohammad, Michel Bottlaender, Eric W. Doran, Ira T. Lott, Isabelle Rivals, Frederic A. Schmitt, Elizabeth Head et al. · 2023 · Translational Psychiatry
  62. Influence of allelic differences in Down syndrome
    Randall J. Roper, Laura E. Hawley, Charles R. Goodlett · 2020 · Progress in brain research
  63. Trisomie 21 et cancers
    Wiem Ayed, Laëtitia Gouas, Frederique Madeleine Penault-Llorca, Ahlem Amouri, Andréï Tchirkov, Philippe Vago · 2012 · Morphologie
  64. Trisomie 21 : 50 ans entre médecine et science
    CATHERINE TURLEAU, Michel J. J. Vekemans · 2010 · médecine/sciences
  65. Selection of oligonucleotides for whole-genome microarrays with semi-automatic update
    Geoffroy Golfier, Sophie Lemoine, A. van Miltenberg, A. Bendjoudi, Jean Rossier, Stéphane Le Crom, Marie‐Claude Potier · 2008 · Bioinformatics
  66. Autisms
    Antonio Maria Persico · 2013 · Elsevier eBooks
  67. Mental Retardation and Human Chromosome 21 Gene Overdosage: From Functional Genomics and Molecular Mechanisms Towards Prevention and Treatment of the Neuropathogenesis of Down Syndrome
    Mohammed Rachidi, Carmela Lopes · 2010 · Advances in neurobiology
  68. Genes Associated with Disturbed Cerebral Neurogenesis in the Embryonic Brain of Mouse Models of Down Syndrome
    Ishihara, Keiichi · 2021 · Genes
  69. Single‐nucleus analysis reveals oxidative stress in Down syndrome basal forebrain neurons at birth
    Nicole R. West, Kalpana Hanthanan Arachchilage, Sara Knaack, Shawn MacGregor, Masoumeh Hosseini, Ryan D. Risgaard, Pubudu Kumarage, Jose L. Martinez, Su‐Chun Zhang, Daifeng Wang et al. · 2025 · Alzheimer s & Dementia
  70. From the lab to the people: major challenges in the biological treatment of Down syndrome
    Jean Adolphe Rondal · 2021 · AIMS neuroscience
  71. Cognitive Enhancement Therapy for a Model of Down Syndrome
    Frances K. Wiseman · 2009 · Science Translational Medicine
  72. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome
    E. Çağlayan · 2016 · Cell Biology International
  73. Chromosome Instability Syndromes
    R. J McKinlay Gardner, David J. Amor · 2018 · Oxford University Press eBooks
  74. Deficiencia de vitamina A y estado nutricional en pacientes con Síndrome de Down
    Carlos J Chávez, P. Ortega, Jhonatan de Araújo Leal, A. D’Escrivan, R. González, Luis Eduardo Miranda · 2010 · Anales de Pediatría
  75. SLy2 controls the antibody response to pneumococcal vaccine through an IL‐5Rα‐dependent mechanism in B‐1 cells
    Fee Schmitt, Daniel Schäll, Kirsten Bucher, Theresa Isabell Schindler, Andreas Hector, Tilo Biedermann, Michael Zemlin, Dominik Hartl, Sandra Beer‐Hammer · 2014 · European Journal of Immunology
  76. A yeast model of Down syndrome
    Randal X. Moldrich · 2007 · International Journal of Developmental Neuroscience
  77. Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome
    Jacob Dohl, Zoe Treadwell, Christopher Mark Norris, Elizabeth Head · 2025 · Alzheimer s & Dementia
  78. Epigenetics and Down syndrome
    Luis Alfonso González-Molina, Alain D. Dekker, Peter Paul De Deyn, Amalia M. Dolga, Marianne G. Rots · 2024 · Elsevier eBooks
  79. Inverse and Proportional Trans Modulation of Gene Expression in Human Aneuploidies
    Shuai Zhang, Ruixue Wang, Ludan Zhang, James A. Birchler, Lin Sun · 2024 · Genes
  80. Oral Epidemiological Profile and Risk Factors in Adolescents with Different Degrees of Down Syndrome in a Vulnerable Peruvian Rural Population
    Eloy Gamboa, Frank Mayta‐Tovalino, Cinthya Tipe, Ada Robles · 2019 · The Journal of Contemporary Dental Practice
  81. Epigenetics of Down Syndrome
    Akhil Maheshwari, Srijan Singh · 2024 · Newborn
  82. Parental age counseling and screening for fetal trisomy
    R. J. M. Gardner, Grant R. Sutherland, Lisa G. Shaffer · 2011 · Oxford University Press eBooks
  83. A Researcher’s guide to rodent models of Down syndrome: Recent insights and translational perspectives
    Mir Abbas Raza, Andrew Folz, Daniella Balduino Victorino, Zhuo Xing, Xu‐Qiao Chen, Xinxin Zuo, Leah K. Borden, Marie‐Claude Potier, William Cary Mobley, Mara Dierssen et al. · 2026 · STAR Protocols
  84. Pleiotropic effects of trisomy and pharmacologic modulation on structural, functional, molecular, and genetic systems in a Down syndrome mouse model
    Sergi Llambrich, Birger Tielemans, Ellen Saliën, Marta Atzori, Kaat Wouters, Vicky Van Bulck, Mark Platt, Laure Vanherp, Nuria Gallego Fernandez, Laura Grau de la Fuente et al. · 2024 · eLife
  85. Urinary polyomavirus infections in neurodevelopmental disorders
    Ivan Gentile, Laura Altieri, Carla Lintas, Roberto Sacco, Paolo Curatolo, Arianna Benvenuto, Filippo Muratori, Elisa Santocchi, Carmela Bravaccio, Carlo Lenti et al. · 2013 · Open Journal of Psychiatry
  86. Syndrome de Down
    Jean Maurice Delabar · 2010 · médecine/sciences
  87. DYRK1A Overexpression in Mice Downregulates the Gonadotropic Axis and Disturbs Early Stages of Spermatogenesis
    Rodolphe Dard, Manon Moreau, Estelle Parizot, Farah Ghieh, Leslie Brehier, Nadim Kassis, Valérie Serazin-Leroy, Antonin Lamazière, Chrystèle Racine, Nathalie di Clemente et al. · 2021 · Genes
  88. Over‐expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice
    Guillaume Postic, Jean Solarz, Cécile Loubière, Janany Kandiah, Jaysen Sawmynaden, Frédéric Adam, Marie Vilaire-Meunier, Thibaut Léger, Jean‐Michel Camadro, Daniella Balduino Victorino et al. · 2023 · Journal of Cellular and Molecular Medicine
  89. Consequences of Aneuploidy in Cancer: Transcriptome and Beyond
    Milena Dürrbaum, Zuzana Štorchová · 2015 · Recent results in cancer research/Recent Results in Cancer Research
  90. Nonlinear Optics in Doped Silica Glass Integrated Waveguide Structures
    D. Duchesne, Marcello Ferrera, Luca Razzari, Roberto Morandotti, Brent E. Little, Sai T., David J. · 2010 · InTech eBooks
  91. Altered synaptic functions in a humanized mouse model of down syndrome (TcMAC21): Implications for seizure susceptibility
    Li‐Rong Shao, Carl E. Stafstrom · 2025 · Epilepsy Research
  92. Role of cystathionine-β-synthase and hydrogen sulfide in down syndrome
    Csaba Szabó · 2025 · Neurotherapeutics
  93. Combinatorial Gene Effects on the Neural Progenitor Pool in Down Syndrome
    Jie Lu, V. Sheen · 2011 · InTech eBooks
  94. Down Syndrome: A Complex and Interactive Genetic Disorder
    L. Samantha, Joshua D., Philip D. Jeffrey, Randall J. · 2011 · InTech eBooks
  95. The sugar phosphate/phosphate exchanger family SLC37
    Chiara Olcese, Lucia Bartoloni · 2013 · Wiley Interdisciplinary Reviews Membrane Transport and Signalling
  96. Alteraciones visuales y oculares en pacientes con síndrome de Down
    P M Nancy Molina, R Paola Páez, W Clemencia Cordovez · 2008 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  97. Expression divergence and copy number variation in the human genome
    H. Auer · 2008 · Cytogenetic and Genome Research
  98. Expanding the boundaries of gene variation for crop improvement.
    R. L. Phillips, H. W. Rines · 2009 · Induced plant mutations in the genomics era. Proceedings of an International Joint FAO/IAEA Symposium, 2008
  99. Variant Chromosomes and Abnormalities of No Phenotypic Consequence
    Rebecca J Gardner, Grant R. Sutherland, Lisa G. Shaffer · 2011 · Oxford University Press eBooks
  100. Health Problems in Down Syndrome
    Subrata Dey · 2015 · InTech eBooks